rtki cpd and pd 0325901

rtki cpd has been researched along with pd 0325901 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; Hossain, MM; Hu, B; Meng, X; Sun, Y; Zhang, X1

Other Studies

1 other study(ies) available for rtki cpd and pd 0325901

ArticleYear
ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    International journal of oncology, 2016, Volume: 49, Issue:2

    Topics: ADAM17 Protein; Animals; Benzamides; Breast Neoplasms; Chromones; Diphenylamine; ErbB Receptors; Female; Humans; MCF-7 Cells; Mice; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA, Small Interfering; Signal Transduction; Tyrphostins; Xenograft Model Antitumor Assays

2016